(Q56945472)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

title

Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

0 references

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

Gershon Golomb

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

author name string

D W Muller

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

D Gordon

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

R J Levy

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

language of work or name

English

0 references

publication date

1 February 1996

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

published in

American Heart Journal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

volume

131

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

page(s)

211-218

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile

15 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Thrombosis of a flexible coil coronary stent: frequency, predictors and clinical outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Alpha-thrombin induces release of platelet-derived growth factor-like molecule(s) by cultured human endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Regulation of platelet-derived growth factor ligand and receptor gene expression by alpha-thrombin in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Thrombin-induced mitogenesis of vascular SMC is partially mediated by autocrine production of PDGF-AA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Thrombin stimulates proliferation of cultured rat aortic smooth muscle cells by a proteolytically activated receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Coumadin and aspirin in prevention of recurrence after transluminal coronary angioplasty: a randomized study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Aspirin and dipyridamole in the prevention of restenosis after percutaneous transluminal coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Effect of 18- to 24-hour heparin administration for prevention of restenosis after uncomplicated coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Peripheral vascular complications after conventional and complex percutaneous coronary interventional procedures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Vascular complications after balloon and new device angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Site-specific dexamethasone delivery for the prevention of neointimal thickening after vascular stent implantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Local delivery of dexamethasone for prevention of neointimal proliferation in a rat model of balloon angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Local anticoagulation without systemic effect using a polymer heparin delivery system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Effects of thrombin inhibition on the development of acute platelet-thrombus deposition during angioplasty in pigs. Heparin versus recombinant hirudin, a specific thrombin inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Hirudin, heparin, and placebo during deep arterial injury in the pig. The in vivo role of thrombin in platelet-mediated thrombosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Prevention of platelet-rich arterial thrombosis by selective thrombin inhibition

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Effectiveness of recombinant desulphatohirudin in reducing restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Use of a direct antithrombin, hirulog, in place of heparin during coronary angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Initial experience with a direct antithrombin, Hirulog, in unstable angina. Anticoagulant, antithrombotic, and clinical effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Design and characterization of hirulogs: a novel class of bivalent peptide inhibitors of thrombin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Clot-bound thrombin is protected from inhibition by heparin-antithrombin III but is susceptible to inactivation by antithrombin III-independent inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Controlled-release drug delivery of diphosphonates to inhibit bioprosthetic heart valve calcification: release rate modulation with silicone matrices via drug solubility and membrane coating

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Restenosis and the proportional neointimal response to coronary artery injury: Results in a porcine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Major clinical events after coronary stenting. The multicenter registry of acute and elective Gianturco-Roubin stent placement. The Gianturco-Roubin Intracoronary Stent Investigator Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Intracoronary stenting compared with conventional therapy for abrupt vessel closure complicating coronary angioplasty: a matched case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Restenosis after placement of Palmaz-Schatz stents in native coronary arteries. Initial results of a multicenter experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

In-hospital costs associated with new percutaneous coronary devices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Percutaneous polymeric stents in porcine coronary arteries. Initial experience with polyethylene terephthalate stents

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Polymeric stenting in the porcine coronary artery model: differential outcome of exogenous fibrin sleeves versus polyurethane-coated stents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Platelet activation by alpha-thrombin is a receptor-mediated event

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Thrombin is an important mediator of platelet aggregation in stenosed canine coronary arteries with endothelial injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

Experimental models of coronary artery restenosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-8703%2896%2990343-9

10.1016/S0002-8703(96)90343-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:8579010%20AND%20SRC:MED&resulttype=core&format=json

15 October 2019

1 reference